Digital Health's New Power Players: Why AI Startups Are Buying Each Other Instead of Building
Two major acquisitions in late July reveal how AI-native care platforms are racing to consolidate clinical data and provider networks as deal volume hits decade lows.

The digital health sector is entering a new phase of maturity, marked not by explosive growth but by strategic consolidation. Two significant acquisitions announced within 48 hours in late July 2024—Included Health's purchase of Firefly Health and Doctronic's acquisition of Summer Health—signal a fundamental shift in how AI-native healthcare companies are positioning themselves to compete with traditional health systems.
Rather than building clinical capabilities from scratch, scaled platforms are now acquiring what they need most: proprietary patient data, established provider networks, and proven health plan infrastructure. This "buy versus build" strategy reflects both the maturation of digital health and an increasingly difficult fundraising environment that has pushed deal volume to its lowest point in a decade.
The Deals Reshaping Virtual Care
On July 28, Included Health signed a definitive agreement to acquire Firefly Health, a Watertown, Massachusetts-based clinically integrated health plan serving more than 20,000 members nationally. Firefly brings significant value beyond its member base: a 15% demonstrated reduction in total cost of care across its administrative-services-only business, member satisfaction exceeding 90%, and an NCQA-accredited primary care model supported by more than 2,300 in-person, in-home, and specialty partners.
One day later, Doctronic announced its acquisition of Summer Health, a text-based virtual pediatric care platform. The strategic prize here is data: Summer Health's library contains more than 100,000 pediatric text-based patient interactions that Doctronic will use to train specialized AI models. Summer Health founder and CEO Ellen DaSilva is joining Doctronic as senior vice president of partnerships to accelerate enterprise and health plan expansion.
Doctronic, which raised a $40 million Series B in March 2024, has already supported more than 30 million health encounters through its AI chatbot and nationwide physician network offering $39 telehealth visits.
A Market Contracting Toward Consolidation
These acquisitions arrive amid a dramatic contraction in digital health deal activity. According to CB Insights data, global digital health deal volume fell to just 228 transactions in Q2 2024—a decade low and 36% decline from the previous quarter. Volume now sits two-thirds below the 688-deal peak reached in Q2 2022.
Yet median deal size has climbed 54% year-to-date to $7.7 million, indicating that available capital is concentrating in fewer, larger, more strategic transactions. Recent major consolidations include Spring Health's acquisition of Alma in May 2024, creating a combined platform serving more than 170 million people; Hims & Hers Health's purchase of Eucalyptus for up to $1.15 billion in June 2024; Universal Health Services' approximately $835 million acquisition of Talkspace in March 2024; and Sword Health's $285 million purchase of Kaia Health in January 2024.
What This Means for Traditional Healthcare
For health systems, this consolidation wave represents a strategic challenge to their control over primary care access and employer relationships. AI-native platforms are positioning themselves as comprehensive "digital front doors" that bypass hospital-based referral networks entirely, competing directly for employer and payer contracts that have historically been core revenue channels for integrated delivery networks.
The emphasis on acquiring proprietary clinical datasets demonstrates how AI companies are building competitive moats through data rather than physical infrastructure. This approach enables them to train specialized models that could eventually match or exceed traditional care quality at significantly lower costs—a value proposition that may accelerate the shift of primary care volume away from hospital-owned practices.
Sources
Companies in this article
Reporting & accountability
How we maintain accuracy
Health AI Central separates reported facts, analysis, and public-source data. Readers can review our standards, request a correction, or consult the relevant research methodology before relying on a claim.